Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
Publishing timestamp: 2024-10-31 14:21:55
Summary
Bristol Myers Squibb reported third-quarter earnings and revenue that exceeded expectations, driven by strong sales of its blood thinner Eliquis and other key drugs. The pharmaceutical giant also raised its full-year revenue and adjusted earnings forecast, leading to a more positive outlook for the company.
Sentiment: POSITIVE
Keywords: business news, earnings, breaking news, breaking news: earnings, business, pfizer inc, pharmaceuticals, breaking news: business, bristol-myers squibb co, health care industry, biotech and pharmaceuticals, joe biden, biotechnology,
Source: https://www.cnbc.com/2024/10/31/bristol-myers-squibb-bmy-earnings-q3-2024.html